Florida / medicine basics
Does a research label make a peptide a treatment?
A label saying research use only means the product is offered for study. It does not show approval for your care.
Read this page’s source notes ↓Start with the approval record
FDA means Food and Drug Administration.
Online offers may name peptides such as BPC-157 and ipamorelin. Retatrutide is a substance being studied for weight control.
As of September 2026, FDA records show no approved US medicine for any of these three.
Cagrilintide is another substance without an FDA-approved medicine. FDA says neither it nor retatrutide may be used to make medicines to order under federal law.
Finding a substance in a study or an online list of drugs does not mean FDA has approved it as medicine.
For an offer naming one of these substances, ask which problem it claims to treat and which evidence supports the claim.
What does research use only change?
FDA letters reviewed in September 2026 said sellers’ website promises of effects on people showed they were offering the products as medicines. A research-only label did not change that.
Those letters state FDA’s claims about particular sellers. They are not final court decisions.
For some peptide shots, FDA warns that the body may react to the peptide as an invader. It also warns about unwanted substances in the medicine and too little information from people to know whether it could cause harm.
Ask for the exact medicine name. Is it approved for this use, or what rule allows it to be made to order for you? A research label does not answer those questions.
Does taking back a request make a peptide allowed?
Groups had asked FDA to let pharmacies use BPC-157 and other peptides as ingredients in medicines made to order. They later took back those requests. FDA’s page current to April 22, 2026 lists the requests as withdrawn and still shows its safety concerns.
Withdrawing a request does not approve the substance, as of September 2026. It also does not put those ingredients on FDA’s temporary list.
For ingredients on that temporary list, FDA may choose not to act against pharmacies for using them in medicines made to order. The pharmacies must meet stated conditions. This policy does not approve the medicine or promise that making it is lawful.
A claim that a request was withdrawn is not enough to show a medicine may be made for you. Ask whoever writes the prescription to explain the rule that permits it.